Navigation Links
IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
Date:5/8/2008

BOSTON, May 8 /PRNewswire/ -- Informed Clinical Sciences (ICS) Advisory Services Corporation announced today the launch of the company's three-part Intellectual Property (IP) platform. This Platform suite offers content and instruments through a Medical Informatics Review, an Alliance Business Review, and a Health IT Review, each respectively focused on the sciences, business concerns, and enabling technologies underlying the growth of the informatics and e-health landscapes. The platform's offerings will establish strategic thought leadership and thereby shape thinking in the e-health community. These offerings will define the development and distribution of digital informatics instruments (DIIs) by presenting new frameworks for integrating informatics sciences, business models, and trends, and enabling technologies in the emergent e-health landscape. DIIs are built upon the Internet and related technologies and are used by patients, consumers, or clinicians to capture, exchange, analyze, and present healthcare information so that care is informed by experience, evidence, prediction, and preference. Bringing science, business, and technology to bear will drive the strategic direction and tactical realization of improved care delivery.

With a core aim of fueling research, development, and adoption strategies and efforts, the ICS Advisory Services Corporation IP platform will be offered to both e-health and diverse healthcare industry participants, and present thinking and evidence regarding how DIIs can solve many of the challenges currently facing the healthcare delivery system. It will combine strategic market analysis, technical and business briefs with key action item "takeaways," case studies, scientific analysis tools, and documented best practices and perspectives on implementing "Best in Context"(TM) solutions care delivery. Professional services in the form of commissioned research or strategy and assessment in any of these three areas of core
'/>"/>

SOURCE Informed Clinical Sciences Advisory Services Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Advanced Life Sciences Announces First Quarter 2008 Financial Results
2. Battelle Collaborating With Korean Partners to Advance Energy Efficiency and Health and Life Sciences Initiatives in Korea
3. Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference
4. Caliper Life Sciences to Present at Deutsche Banks 33rd Annual Health Care Conference
5. Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
6. Caliper Life Sciences and DiscoveRx Collaborate to Offer Solutions for Cell-Based GPCR Profiling and Lead Optimization
7. YM BIOSCIENCES ANNOUNCES PRESENTATIONS FOR AEROLEF(TM) AT AMERICAN PAIN SOCIETY ANNUAL MEETING
8. Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail
9. Advanced Life Sciences to Host 2008 First Quarter Financial Results Conference Call and Webcast
10. Edwards Lifesciences to Webcast Annual Stockholders Meeting
11. Pressure BioSciences, Inc. to Discuss First Quarter 2008 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5